Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,720 | -30,430 | -24,789 | -17,301 | -8,631 |
| Depreciation Amortization | 12 | 217 | 191 | 189 | 170 |
| Accounts payable and accrued liabilities | 119 | -1,364 | -438 | 287 | -1,419 |
| Other Working Capital | -890 | -2,314 | -1,624 | -1,574 | -3,000 |
| Other Operating Activity | 446 | 4,243 | 2,823 | 1,608 | 2,468 |
| Operating Cash Flow | $-8,033 | $-29,648 | $-23,837 | $-16,791 | $-10,412 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -30 | 26,000 | N/A | N/A |
| Other Investing Activity | 0 | 26,000 | 0 | 26,000 | 26,000 |
| Investing Cash Flow | $N/A | $25,970 | $26,000 | $26,000 | $26,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 70 | 70 | 70 | 26 |
| Other Financing Activity | -18 | -262 | -262 | -262 | -192 |
| Financing Cash Flow | $-18 | $-192 | $-192 | $-192 | $-166 |
| Beginning Cash Position | 94,809 | 98,679 | 98,679 | 98,679 | 98,679 |
| End Cash Position | 86,758 | 94,809 | 100,650 | 107,696 | 114,101 |
| Net Cash Flow | $-8,051 | $-3,870 | $1,971 | $9,017 | $15,422 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,033 | -29,648 | -23,837 | -16,791 | -10,412 |
| Capital Expenditure | N/A | -30 | 26,000 | N/A | N/A |
| Free Cash Flow | -8,033 | -29,678 | 2,163 | -16,791 | -10,412 |